ESMO Advanced Course on NTRK Gene Fusion - A New Target in Precision Treatment of Cancer
- Start date
- 21 Oct 2019
- End date
- 22 Oct 2019
- Location
- Barcelona, Spain
Learning Objectives
- Acquire knowledge of the TRK Family members and their roles in ontogenesis
- Understand the mechanisms of gene fusion and the different fusion partners involved
- Learn how TRK receptors are structured and how their activation impacts signal transduction
- Review the epidemiology of NTRK gene fusion in human tumours
- Understand the methodology to identify NTRK gene fusion and the challenges of testing
- Update your knowledge on the present outcome obtained with NTRK inhibitors, their toxicities and clinical management
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Elena Garralda, Spain
- Caterina Marchiò, Italy